We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Circassia Group Plc | LSE:CIR | London | Ordinary Share | GB00BJVD3B28 | ORD 0.08P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 34.00 | 33.10 | 34.90 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
19/12/2019 06:10 | Nice fresh thread with all the info in the header, ready for what should be a very progressive and fruitful 2020 and 21. | pro_s2009 | |
19/12/2019 02:14 | Link to the Sept Webcast which goes through the presentation. . | pro_s2009 | |
19/12/2019 02:12 | Link to their Sept 2019 Presentation: . | pro_s2009 | |
19/12/2019 02:10 | Thanks to the abbot the abbot 17 Dec '19 - 11:12 - 945 of 964 Updated 17/12/2019 I have had to make some assumptions as follows; 1. Woodford. The standard is to record when a shareholder is less than 5% and less than 3% - Circassia has had the less than 5% for woodford, but NOT the less than 3% TR-1 thus I have assumed for now woodford at 3%. 2. I have assumed (in the calculation) no shareholding for Morgan Stanley and IP Group even though we have only ever had a less than 3% TR-1. I expect though they hold some shares as we did get 0% updates in the past for Spreadex and St James place. All other inputs are exact based on recorded RNS data thus we have no greater than 11% of shares available, but this could be as low as 6% if MS and IP still hold. Only thing we do know for fact are below: Last update -------- Shareholder -------Percentage--- 03/12/2019 ----------oryx -------------- 7.996% -------------30,000, 27/11/2019 ----------lombard ------------5.08% --------------19,059 26/11/2019 ----------griffiths ----------27.29% ------------102,389, 26/11/2019 ----------Societe Generale ---1.45% ---------------5,440 25/11/2019 ----------Invesco ------------13.85% -------------51,963, 11/02/2019 ----------Neptune ------------4.78% --------------17,934 18/07/2019 ----------AstraZenec 16/09/2019 ----------woodford-- 20/07/2019 ----------St James Place ---- 0.00% -------------------- Last update Director Shareholding last AR + PMDR S Harris ----------1.59% ----------5,959,952 last AR + PMDR J Cotta ----------0.01% ----------46,875 last AR + PMDR R Hafner ----------0.24%----- last AR + PMDR F Granata ----------0.08% ----------312,500 last AR + PMDR J Emms ----------0.08% ----------300,000 Total Shares held ---- 333,581,378 Total Shares --------- 375,188,718 Difference ------------ 41,607,340 UNKNOWN -------------------- Below 3% 21/05/2019 Morgan Stanley 26/11/2019 Spreadex Below 5% 16/09/2019 Woodford | pro_s2009 | |
19/12/2019 02:05 | As the header of this thread is way out of date and not been updated for a long time, I have added a new thread as below for CIR. All welcome to use the new one. . | pro_s2009 | |
19/12/2019 02:03 | !YOUTUBEVIDEO:S8G9MH Circassia is a dedicated diagnostics and management company focused on asthma. Our market-leading NIOX® products are used by physicians around the world to help improve asthma diagnosis and management, and we support our customers with dedication to outstanding customer service and after sales support. Our purpose is to improve the quality of life for millions of people suffering from asthma. As the leading provider of point-of-care FeNO diagnosis and management products we are making good progress, helping healthcare professionals manage their patients’ asthma. We believe every asthma patient should have access to the best care. To help achieve this, we are working hard to provide our customers with outstanding support, while devoting ourselves to developing the next generation of NIOX® innovations. Our history Circassia was established in 2006, and in 2014 we completed an initial public offering on the London Stock Exchange. A year later, we acquired the NIOX® range of products, broadening our portfolio. Circassia is now dedicated to asthma point-of-care diagnosis and management, with a clear mission, market-leading products and strong commercial organization dedicated to providing outstanding customer support. Web site : . | pro_s2009 | |
18/12/2019 09:30 | sudden reverse | timmy11 | |
18/12/2019 08:31 | 600k @ 21 = £126k buy. Institutions loading. | x54v | |
18/12/2019 00:22 | enteleon, I believe there will be a very strong January rally in the UK markets - all good stocks should see significant gains in January and I fully expect CIR to rally in January. | pro_s2009 | |
17/12/2019 17:19 | Pro s2209- could not agree more ! We have entered quadruple witching week (end-date Friday Dec 20th) and there is always showcasing by the iis for end calendar-year. Fascinating to watch how the next ten or so trading days work out. | enteleon | |
17/12/2019 16:46 | Oh gone on. | m5 | |
17/12/2019 16:25 | pls don't bring the stripper out...... | purple11 | |
17/12/2019 15:11 | 2 year chart in the header currently looking good. Breakout from a low base, pullback to re-test the breakout and now starting to move back up again. | x54v | |
17/12/2019 14:56 | Indeed. I "c" | m5 | |
17/12/2019 14:52 | excited I hope | knowing | |
17/12/2019 14:45 | Added again today. I am quite exited about this one for 2020. Nice to see a fairly quiet BB aswell. | m5 | |
17/12/2019 13:57 | Whoooo gal slow and easy there the best rises out there 🐰 | linton5 | |
17/12/2019 11:58 | IP group sold out completely in July before all the good news. They mentioned the sale in their interim report. | bjfanc |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions